Leonard E. Post
Director
Pharmaceutical Sciences
Custom Recreational Specialties
Canada
Biography
Dr. Post has over 30 years of experience in all stages of pharmaceutical and biotechnology company R&D from early drug discovery through clinical development and FDA approval. Dr. Post is currently the chief scientific officer of BioMarin Pharmaceuticals, a publicly traded biopharmaceuticals company with four marketed products and five currently in clinical development. In addition, he sits on the Board of Directors of Altiris Therapeutics and Orphagen Pharmaceuticals (two private biotechnology companies) and Viralytics (a public biotechnology company, listed on the Australian Stock Exchange). Prior to joining BioMarin, Dr. Post held various senior research positions at LEAD Therapeutics, Onyx Pharmaceuticals, and Parke-Davis Pharmaceuticals. He received a Bachelor of Science in chemistry from the University of Michigan and a doctorate in biochemistry from the University of Wisconsin, after which he performed a postdoctoral fellowship in virology at the University of Chicago with Dr. Bernard Roizman.
Research Interest
Pharmaceutical Sciences
